Antibiotic Eye Prophylaxis for Newborns: Using the Topical Erythromycin Shortage as an Opportunity to Reflect on Practice Evolution

J Obstet Gynaecol Can. 2023 May;45(5):329-330. doi: 10.1016/j.jogc.2023.02.014. Epub 2023 Mar 18.

Authors

Elspeth McGregor¹, Erika Bariciak², Stephanie Redpath², Deepti Reddy³, Richard J Webster³, Nicole Le Saux⁴

Affiliations

¹ Division of Neonatology, Department of Pediatrics, University of Ottawa, Ottawa, ON. Electronic address: elspeth.mcgregor@gmail.com.
² Division of Neonatology, Department of Pediatrics, University of Ottawa, Ottawa, ON.
³ Clinical Research Unit, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON.
⁴ Division of Infectious Disease, Department of Pediatrics, University of Ottawa, Ottawa, ON.

PMID: 36934876
DOI: 10.1016/j.jogc.2023.02.014

No abstract available

Publication types

Letter

MeSH terms

Administration, Topical
Anti-Bacterial Agents* / therapeutic use
Antibiotic Prophylaxis
Erythromycin* / therapeutic use
Humans
Infant, Newborn

Substances

Anti-Bacterial Agents
Erythromycin